NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q3 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $452,854 | -11.5% | 10,234 | -2.6% | 0.00% | 0.0% |
| Q2 2023 | $511,465 | -15.1% | 10,511 | -3.1% | 0.00% | 0.0% |
| Q1 2023 | $602,392 | +137747.1% | 10,850 | -0.3% | 0.00% | 0.0% |
| Q4 2022 | $437 | -99.9% | 10,882 | -1.1% | 0.00% | 0.0% |
| Q3 2022 | $482,000 | -11.2% | 11,005 | -28.2% | 0.00% | -50.0% |
| Q2 2022 | $543,000 | -19.1% | 15,321 | -7.1% | 0.00% | 0.0% |
| Q1 2022 | $671,000 | -59.4% | 16,490 | -6.9% | 0.00% | -50.0% |
| Q4 2021 | $1,654,000 | -14.3% | 17,712 | +2.2% | 0.00% | -20.0% |
| Q3 2021 | $1,931,000 | +15.4% | 17,329 | +17.6% | 0.01% | +25.0% |
| Q2 2021 | $1,673,000 | +9.3% | 14,734 | -2.2% | 0.00% | 0.0% |
| Q1 2021 | $1,530,000 | +19.4% | 15,070 | +17.1% | 0.00% | 0.0% |
| Q4 2020 | $1,281,000 | +45.1% | 12,869 | +5.3% | 0.00% | +33.3% |
| Q3 2020 | $883,000 | +27.8% | 12,226 | -11.8% | 0.00% | 0.0% |
| Q2 2020 | $691,000 | +225.9% | 13,857 | +94.8% | 0.00% | +200.0% |
| Q1 2020 | $212,000 | – | 7,113 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 3,100,560 | $314,831,000 | 18.93% |
| Blue Water Life Science Advisors, LP | 328,836 | $33,390,000 | 16.31% |
| Foresite Capital Management III, LLC | 127,305 | $12,927,000 | 11.35% |
| HWG Holdings LP | 148,794 | $15,109,000 | 7.53% |
| Eagle Health Investments LP | 168,394 | $17,099,000 | 6.71% |
| Lagoda Investment Management, L.P. | 103,325 | $10,492,000 | 5.24% |
| Ally Bridge Group (NY) LLC | 218,000 | $22,136,000 | 4.24% |
| PERKINS CAPITAL MANAGEMENT INC | 63,950 | $6,493,000 | 3.76% |
| BRIDGER MANAGEMENT, LLC | 388,620 | $39,460,000 | 3.68% |
| Hudson Executive Capital LP | 527,086 | $53,520,000 | 3.32% |